Literature DB >> 18439434

Effects of oxidative and nitrosative stress in brain on p53 proapoptotic protein in amnestic mild cognitive impairment and Alzheimer disease.

Giovanna Cenini1, Rukhsana Sultana, Maurizio Memo, D Allan Butterfield.   

Abstract

Many studies reported that oxidative and nitrosative stress might be important for the pathogenesis of Alzheimer's disease (AD) beginning with arguably the earliest stage of AD, i.e., as mild cognitive impairment (MCI). p53 is a proapoptotic protein that plays an important role in neuronal death, a process involved in many neurodegenerative disorders. Moreover, p53 plays a key role in the oxidative stress-dependent apoptosis. We demonstrated previously that p53 levels in brain were significantly higher in MCI and AD IPL (inferior parietal lobule) compared to control brains. In addition, we showed that in AD IPL, but not in MCI, HNE, a lipid peroxidation product, was significantly bound to p53 protein. In this report, we studied by means of immunoprecipitation analysis, the levels of markers of protein oxidation, 3-nitrotyrosine (3-NT) and protein carbonyls, in p53 in a specific region of the cerebral cortex, namely the inferior parietal lobule, in MCI and AD compared to control brains. The focus of these studies was to measure the oxidation and nitration status of this important proapoptotic protein, consistent with the hypothesis that oxidative modification of p53 could be involved in the neuronal loss observed in neurodegenerative conditions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18439434      PMCID: PMC2587421          DOI: 10.1016/j.freeradbiomed.2008.03.015

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  46 in total

Review 1.  Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide.

Authors:  D A Butterfield; J Drake; C Pocernich; A Castegna
Journal:  Trends Mol Med       Date:  2001-12       Impact factor: 11.951

2.  Peroxynitrite-induced alterations in synaptosomal membrane proteins: insight into oxidative stress in Alzheimer's disease.

Authors:  T Koppal; J Drake; S Yatin; B Jordan; S Varadarajan; L Bettenhausen; D A Butterfield
Journal:  J Neurochem       Date:  1999-01       Impact factor: 5.372

Review 3.  Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress.

Authors:  D Allan Butterfield; Christopher M Lauderback
Journal:  Free Radic Biol Med       Date:  2002-06-01       Impact factor: 7.376

Review 4.  Zinc binding and redox control of p53 structure and function.

Authors:  P Hainaut; K Mann
Journal:  Antioxid Redox Signal       Date:  2001-08       Impact factor: 8.401

Review 5.  Advanced Maillard reaction end products, free radicals, and protein oxidation in Alzheimer's disease.

Authors:  M A Smith; P L Richey; S Taneda; R K Kutty; L M Sayre; V M Monnier; G Perry
Journal:  Ann N Y Acad Sci       Date:  1994-11-17       Impact factor: 5.691

6.  Oxidatively modified GST and MRP1 in Alzheimer's disease brain: implications for accumulation of reactive lipid peroxidation products.

Authors:  Rukhsana Sultana; D Allan Butterfield
Journal:  Neurochem Res       Date:  2004-12       Impact factor: 3.996

Review 7.  Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated proteins.

Authors:  D A Butterfield; J Kanski
Journal:  Mech Ageing Dev       Date:  2001-07-15       Impact factor: 5.432

8.  Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1.

Authors:  Alessandra Castegna; Michael Aksenov; Marina Aksenova; Visith Thongboonkerd; Jon B Klein; William M Pierce; Rosemarie Booze; William R Markesbery; D Allan Butterfield
Journal:  Free Radic Biol Med       Date:  2002-08-15       Impact factor: 7.376

9.  Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease.

Authors:  D Allan Butterfield; H Fai Poon; Daret St Clair; Jeffery N Keller; William M Pierce; Jon B Klein; William R Markesbery
Journal:  Neurobiol Dis       Date:  2006-02-08       Impact factor: 5.996

10.  Inactivation of wild-type p53 protein function by reactive oxygen and nitrogen species in malignant glioma cells.

Authors:  Charles S Cobbs; Thomas R Whisenhunt; Duane R Wesemann; Lualhati E Harkins; Erwin G Van Meir; Minu Samanta
Journal:  Cancer Res       Date:  2003-12-15       Impact factor: 12.701

View more
  26 in total

Review 1.  Mechanisms of altered redox regulation in neurodegenerative diseases--focus on S--glutathionylation.

Authors:  Elizabeth A Sabens Liedhegner; Xing-Huang Gao; John J Mieyal
Journal:  Antioxid Redox Signal       Date:  2012-01-06       Impact factor: 8.401

2.  Corticotropin-Releasing Factor Receptor-1 Antagonism Reduces Oxidative Damage in an Alzheimer’s Disease Transgenic Mouse Model.

Authors:  Cheng Zhang; Ching-Chang Kuo; Setareh H Moghadam; Louise Monte; Kenner C Rice; Robert A Rissman
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

3.  Protein levels of heat shock proteins 27, 32, 60, 70, 90 and thioredoxin-1 in amnestic mild cognitive impairment: an investigation on the role of cellular stress response in the progression of Alzheimer disease.

Authors:  Fabio Di Domenico; Rukhsana Sultana; Georgianne F Tiu; Nicole N Scheff; Marzia Perluigi; Chiara Cini; D Allan Butterfield
Journal:  Brain Res       Date:  2010-04-01       Impact factor: 3.252

Review 4.  Unraveling the complexity of neurodegeneration in brains of subjects with Down syndrome: insights from proteomics.

Authors:  Marzia Perluigi; Fabio Di Domenico; D Allan Buttterfield
Journal:  Proteomics Clin Appl       Date:  2014-02       Impact factor: 3.494

Review 5.  Cell cycle proteins in brain in mild cognitive impairment: insights into progression to Alzheimer disease.

Authors:  Jeriel T R Keeney; Aaron M Swomley; Jessica L Harris; Ada Fiorini; Mihail I Mitov; Marzia Perluigi; Rukhsana Sultana; D Allan Butterfield
Journal:  Neurotox Res       Date:  2011-11-15       Impact factor: 3.911

6.  Activation of p53 in Down Syndrome and in the Ts65Dn Mouse Brain is Associated with a Pro-Apoptotic Phenotype.

Authors:  Antonella Tramutola; Gilda Pupo; Fabio Di Domenico; Eugenio Barone; Andrea Arena; Chiara Lanzillotta; Diede Brokeaart; Carla Blarzino; Elizabeth Head; D Allan Butterfield; Marzia Perluigi
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

Review 7.  Oxidative stress and β-amyloid protein in Alzheimer's disease.

Authors:  Zhiyou Cai; Bin Zhao; Anna Ratka
Journal:  Neuromolecular Med       Date:  2011-09-08       Impact factor: 3.843

Review 8.  The 2013 SFRBM discovery award: selected discoveries from the butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairment.

Authors:  D Allan Butterfield
Journal:  Free Radic Biol Med       Date:  2014-07-01       Impact factor: 7.376

9.  Alterations in brain antioxidant enzymes and redox proteomic identification of oxidized brain proteins induced by the anti-cancer drug adriamycin: implications for oxidative stress-mediated chemobrain.

Authors:  G Joshi; C D Aluise; M P Cole; R Sultana; W M Pierce; M Vore; D K St Clair; D A Butterfield
Journal:  Neuroscience       Date:  2010-01-20       Impact factor: 3.590

Review 10.  Critical Evaluation of the Changes in Glutamine Synthetase Activity in Models of Cerebral Stroke.

Authors:  Thomas M Jeitner; Kevin Battaile; Arthur J L Cooper
Journal:  Neurochem Res       Date:  2015-08-02       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.